World's Best Scientists 2026 revealed!
Ryad Tamouza

Ryad Tamouza

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 53 3984 3673 189 172 249 9984

Ryad Tamouza publications per year

The chart shows the history of publications by Ryad Tamouza between 1996 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Ryad Tamouza published across 30 years, from 1996 to 2025, averaging 9.5 papers a year. Output peaked at 33 publications in 2021. 20 of the 285 publications appeared in the last two years.

No. of publications
10 20 30
Bar chart. Horizontal axis: year, 1996 to 2025. Vertical axis: number of publications, 0 to 33. Peak 33 publications in 2021. 1996: 3 publications 1997: 4 publications 1998: 4 publications 1999: 4 publications 2000: 0 publications 2001: 5 publications 2002: 4 publications 2003: 4 publications 2004: 6 publications 2005: 6 publications 2006: 5 publications 2007: 8 publications 2008: 1 publication 2009: 9 publications 2010: 0 publications 2011: 7 publications 2012: 6 publications 2013: 17 publications 2014: 23 publications 2015: 20 publications 2016: 11 publications 2017: 14 publications 2018: 13 publications 2019: 15 publications 2020: 18 publications 2021: 33 publications 2022: 9 publications 2023: 16 publications 2024: 16 publications 2025: 4 publications
1996 2025

285 publications in total across all disciplines

View publications per year as a table
Ryad Tamouza: publications per year, 1996 to 2025
Year Publications
1996 3
1997 4
1998 4
1999 4
2000 0
2001 5
2002 4
2003 4
2004 6
2005 6
2006 5
2007 8
2008 1
2009 9
2010 0
2011 7
2012 6
2013 17
2014 23
2015 20
2016 11
2017 14
2018 13
2019 15
2020 18
2021 33
2022 9
2023 16
2024 16
2025 4
Total 285
Download as CSV

Ryad Tamouza publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Ryad Tamouza sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 242–251 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 249 publications — 51st percentile

51% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160 249
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Ryad Tamouza D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Ryad Tamouza sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 52–53 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 53 D-Index — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177 53
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Ryad Tamouza is a researcher affiliated with Inserm in France. Their scholarly work primarily spans the fields of Medicine, Neuroscience, and Immunology and Microbiology, with a significant focus on Biological Psychiatry, Immunology, Neurology, Psychiatry and Mental Health, and Genetics as subfields. The researcher's expertise covers a wide array of topics including tryptophan and brain disorders, immune cell function and interaction, bipolar disorder and treatment, stress responses and cortisol, genetics and neurodevelopmental disorders, COVID-19 and mental health, as well as the long-term effects of COVID-19.

The publication record of Ryad Tamouza includes contributions to various scientific venues, particularly those with a recurrent thematic focus. The most frequent publication venues are Brain Behavior and Immunity, Translational Psychiatry, European Neuropsychopharmacology, Brain Behavior & Immunity - Health, and bioRxiv. This reflects the scientist's engagement in fields related to neuroimmunology and psychiatric disorders.

Among the recent papers co-authored by Ryad Tamouza, notable works include:

  • Mental disorders and risk of COVID-19-related mortality, hospitalisation, and intensive care unit admission: a systematic review and meta-analysis (2021, The Lancet Psychiatry)
  • Immunological causes of obsessive-compulsive disorder: is it time for the concept of an "autoimmune OCD" subtype? (2022, Translational Psychiatry)
  • Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis (2021, Neurology Neuroimmunology & Neuroinflammation)
  • Anti-CASPR2 clinical phenotypes correlate with HLA and immunological features (2020, Journal of Neurology Neurosurgery & Psychiatry)
  • Severe mental illness and European COVID-19 vaccination strategies (2021, The Lancet Psychiatry)

Ryad Tamouza has collaborated extensively with several co-authors, among whom Marion Leboyer, Wahid Boukouaci, Ching-Lien Wu, Philippe Le Corvoisier, and Ophélia Godin stand out due to the frequency of their joint publications. These partnerships suggest a collaborative approach that spans immunology, psychiatry, and neuroscience research.

Best Publications

  • Can bipolar disorder be viewed as a multi-system inflammatory disease?

    Marion Leboyer;Isabella Soreca;Jan Scott;Jan Scott;Mark Frye

  • Immunoneuropsychiatry - novel perspectives on brain disorders.

    Katrin Pape;Ryad Tamouza;Ryad Tamouza;Marion Leboyer;Marion Leboyer;Frauke Zipp

  • CD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA Interactions

    Matthieu Allez;Vannary Tieng;Atsushi Nakazawa;Xavier Treton

  • The "psychomicrobiotic": Targeting microbiota in major psychiatric disorders: A systematic review

    G. Fond;W. Boukouaci;G. Chevalier;A. Regnault

  • HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis

    Genin E;Chen Dp;Chen Dp;Hung Si;Sekula P

  • HLA Association with Hematopoietic Stem Cell Transplantation Outcome: The Number of Mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 Is Strongly Associated with Overall Survival

    Pascale Loiseau;Marc Busson;Marie-Lorraine Balere;Anne Dormoy

  • Immunological and autoimmune considerations of Autism Spectrum Disorders

    Benjamin Gesundheit;Joshua P. Rosenzweig;David Naor;Bernard Lerer

  • Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.

    Gerard Socie;Pascale Loiseau;Ryad Tamouza;Anne Janin

  • Effectiveness and tolerance of anti-inflammatory drugs' add-on therapy in major mental disorders: a systematic qualitative review.

    G. Fond;N. Hamdani;F. Kapczinski;W. Boukouaci

  • BCR/ABL Oncogene Directly Controls MHC Class I Chain-Related Molecule A Expression in Chronic Myelogenous Leukemia

    Nicolas Boissel;Delphine Rea;Vannary Tieng;Nicolas Dulphy

  • An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation

    Nicolas Dulphy;Nicolas Dulphy;Philippe Haas;Marc Busson;Stéphanie Belhadj

  • Dynamic disorganization of synaptic NMDA receptors triggered by autoantibodies from psychotic patients

    Julie Jézéquel;Emily M. Johansson;Julien P. Dupuis;Véronique Rogemond;Véronique Rogemond

  • Relationship between Toxoplasma gondii infection and bipolar disorder in a French sample

    Nora Hamdani;Nora Hamdani;Claire Daban-Huard;Claire Daban-Huard;Mohamed Lajnef;Mohamed Lajnef;Jean Romain Richard;Jean Romain Richard

  • Molecular characteristics of Human Endogenous Retrovirus type-W in schizophrenia and bipolar disorder

    H Perron;N Hamdani;R Faucard;M Lajnef

  • Association between Parkinson's disease and the HLA‐DRB1 locus

    Ismaïl Ahmed;Ryad Tamouza;Marc Delord;Rajagopal Krishnamoorthy

  • Immunity, Inflammation, and Bipolar Disorder: Diagnostic and Therapeutic Implications

    Nora Hamdani;Raphael Doukhan;Ozlem Kurtlucan;Ryad Tamouza

  • Is it time for immunopsychiatry in psychotic disorders

    Marion Leboyer;José Oliveira;José Oliveira;Ryad Tamouza;Laurent Groc

  • MICA-129 genotype, soluble MICA, and anti-MICA antibodies as biomarkers of chronic graft-versus-host disease

    Wahid Boukouaci;Marc Busson;Régis Peffault de Latour;Vanderson Rocha

  • Association of drug metabolism gene polymorphisms with toxicities, graft-versus-host disease and survival after HLA-identical sibling hematopoietic stem cell transplantation for patients with leukemia

    V Rocha;R Porcher;J F Fernandes;A Filion

  • A single tumour necrosis factor haplotype influences the response to adalimumab in rheumatoid arthritis

    Corinne Miceli-Richard;Emmanuelle Comets;C. Verstuyft;Ryad Tamouza

  • Functional study of TNF-α promoter polymorphisms : literature review and meta-analysis

    Arsene Mekinian;Ryad Tamouza;Stephan Pavy;Nicolas Gestermann

  • Clinical and Prognostic Value of Immunogenetic Characteristics in Anti-LGI1 Encephalitis.

    Sergio Muñiz-Castrillo;Julie Haesebaert;Laure Thomas;Alberto Vogrig

Frequent Co-Authors

Dominique Charron
Dominique Charron Grenoble Alpes University
Marion Leboyer
Marion Leboyer Paris-Est Créteil University
Rajagopal Krishnamoorthy
Rajagopal Krishnamoorthy Inserm : Institut national de la santé et de la recherche médicale
Antoine Toubert
Antoine Toubert Université Paris Cité
Marc Busson
Marc Busson Grenoble Alpes University
Vanderson Rocha
Vanderson Rocha Universidade de São Paulo
Eliane Gluckman
Eliane Gluckman Université Paris Cité
Gérard Socié
Gérard Socié Université Paris Cité
Pascale Loiseau
Pascale Loiseau Hôpital Saint-Louis

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those exploring the field of Immunology, pursuing related online degrees can open diverse career opportunities in healthcare and research. Nursing programs, for example, offer accelerated pathways to enter clinical roles more quickly. The accelerated np program is ideal for individuals seeking advanced practice roles with a focus on patient care and immunological health.

Non-nurses interested in healthcare careers can benefit from online accelerated nursing programs for non nurses. These programs fast-track foundational nursing knowledge, crucial for understanding immunological treatments and interventions in medical settings.

For those looking to complete their Bachelor of Science in Nursing quickly, the 12-month accelerated nursing programs provide a practical solution. They offer an intense but time-efficient route into nursing, closely aligned with immunology-based patient care specialties.

Similarly, aspiring Licensed Practical Nurses can explore the fastest and easiest lpn programs, providing quick entry into healthcare roles that support immunology research and treatment teams. These programs emphasize hands-on skills essential for immunology-related healthcare settings.

Best Scientists Citing Ryad Tamouza

Trending Scientists

Recently Published Articles